Key stats
About J.MOLNER AS
Sector
Headquarters
Tallinn
Founded
2015
Website
ISIN
EE3100109034
FIGI
BBG01B6CYS02
J. Molner AS operates as a global pharmaceutical company. It focuses on sterile injectable and dermatological drugs for both the United States and Canada. The company was founded by Jason Michael Atticus Grenfell-Gardner in 2015 and is headquartered in Tallinn, Estonia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MOLNR is 20.4 EUR — it has decreased by −5.66% in the past 24 hours. Watch J.MOLNER AS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXTSE exchange J.MOLNER AS stocks are traded under the ticker MOLNR.
MOLNR stock has fallen by −4.76% compared to the previous week, the month change is a 4.71% rise, over the last year J.MOLNER AS has showed a 81.33% increase.
MOLNR reached its all-time high on Oct 30, 2024 with the price of 21.6 EUR, and its all-time low was 5.0 EUR and was reached on Apr 5, 2023. View more price dynamics on MOLNR chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MOLNR stock is 1.98% volatile and has beta coefficient of 0.06. Track J.MOLNER AS stock price on the chart and check out the list of the most volatile stocks — is J.MOLNER AS there?
No, MOLNR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MOLNR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade J.MOLNER AS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So J.MOLNER AS technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating J.MOLNER AS stock shows the neutral signal. See more of J.MOLNER AS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.